Zimmer Biomet Holdings, Inc.ZBHNYSE

Overview Intelligence Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

24 analysts·High coverage

33%

Rating Distribution

Strong Buy

00%

Buy

833%

Hold

1458%

Sell

28%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 8% higher.

Bear Case

$89.00

-11%

Consensus

$107.82

+8%

Bull Case

$130.00

+31%

Price Range24 analysts

Low

Consensus

High

$89.00

$130.00

Current Target

Current Price

$99.49

Upside to Target

$8.33

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$8.40(17 analysts)

P/E28x

Current: 27.5x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+3.72%

EPS+7.10%

FY2028

Rev+3.57%

EPS+6.04%

FY2029

Rev+5.51%

EPS+8.39%

Earnings Surprises

Beat rate:75%(9/12 quarters)

Avg surprise:+2.9%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 12, 2026Barclays

Zimmer Biomet price target lowered to $100 from $104 at Barclays

Target:$100.00

+3.4%from $96.69

Feb 11, 2026UBS

Zimmer Biomet price target raised to $89 from $86 at UBS

Target:$89.00

-5.0%from $93.69

Jan 28, 2026UBS

Zimmer Biomet price target lowered to $86 from $88 at UBS

Target:$86.00

+0.9%from $85.27

Jan 9, 2026Bernstein

Zimmer Biomet price target raised to $99 from $97 at Bernstein

Target:$99.00

+5.2%from $94.08

Jan 9, 2026Goldman Sachs

Zimmer Biomet downgraded to Sell from Neutral at Goldman Sachs

Target:$93.00

-1.1%from $94.08

Jan 5, 2026Evercore ISI

Zimmer Biomet upgraded to Outperform from In Line at Evercore ISI

Target:$120.00

+33.3%from $90.02

Dec 16, 2025Robert W. Baird

Zimmer Biomet downgraded to Neutral from Outperform at Baird

Target:$100.00

+8.1%from $92.52

Nov 5, 2025Stifel Nicolaus

Zimmer Biomet price target lowered to $110 from $118 at Stifel

Target:$110.00

+25.1%from $87.91

Nov 5, 2025Johnson Rice

Zimmer Biomet price target lowered to $112 from $122 at BTIG

Target:$112.00

+27.2%from $88.05

Nov 5, 2025Barclays

Zimmer Biomet price target lowered to $105 from $112 at Barclays

Target:$105.00

+1.8%from $103.18

Oct 13, 2025BTIG

Zimmer Biomet price target raised to $122 from $118 at BTIG

Target:$122.00

+28.8%from $94.71

Oct 10, 2025RBC Capital

Zimmer Biomet price target lowered to $111 from $115 at RBC Capital

Target:$111.00

+16.2%from $95.53

Sep 19, 2025Stifel Nicolaus

Zimmer Biomet price target raised to $118 from $115 at Stifel

Target:$118.00

+17.6%from $100.36

Sep 18, 2025Redburn Partners

Zimmer Biomet initiated with a Buy at Rothschild & Co Redburn

Target:$130.00

+29.7%from $100.21

Aug 8, 2025UBS

Zimmer Biomet price target raised to $96 from $91 at UBS

Target:$96.00

-2.0%from $97.94

May 6, 2025Truist Financial

Zimmer Biomet price target lowered to $101 from $113 at Truist

Target:$101.00

+9.5%from $92.27

May 6, 2025RBC Capital

Zimmer Biomet price target lowered to $112 from $125 at RBC Capital

Target:$112.00

+21.4%from $92.27

May 6, 2025Stifel Nicolaus

Zimmer Biomet price target lowered to $115 from $138 at Stifel

Target:$115.00

+27.1%from $90.48

May 5, 2025Wells Fargo

Zimmer Biomet price target lowered to $98 from $113 at Wells Fargo

Target:$98.00

+8.3%from $90.48

Oct 31, 2024Truist Financial

Zimmer Biomet (ZBH) PT Raised to $117 at Truist Securities

Target:$117.00

+9.4%from $106.92

Oct 15, 2024Oppenheimer

Zimmer Biomet (ZBH) PT Lowered to $135 at Oppenheimer

Target:$135.00

+28.8%from $104.83

Oct 3, 2024BTIG

Zimmer Biomet price target lowered to $126 from $134 at BTIG

Target:$126.00

+19.2%from $105.69

Oct 1, 2024Evercore ISI

Zimmer Biomet price target lowered to $110 from $113 at Evercore ISI

Target:$110.00

+1.9%from $107.95

Sep 13, 2024Truist Financial

Zimmer Biomet price target lowered to $112 from $117 at Truist

Target:$112.00

+6.5%from $105.14

Sep 10, 2024Canaccord Genuity

Zimmer Biomet price target lowered to $115 from $120 at Canaccord

Target:$115.00

+9.7%from $104.83

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance